Skip navigation
Speakers

Ensure Compliance in Specialty Pharmacy Arrangements, Patient Support Programs and Evolving Drug Pricing Transparency Legislation

December 4-5, 2018
  • Philadelphia, PA

James Accumanno
Director, Risk, Monitoring & Auditing
Novo Nordisk Inc.

Michelle D. Axelrod
Principal, Porzio, Bromberg & Newman, PC;
Vice President, Porzio Life Sciences, LLC

Kosha R. Brightwell
Consultant

James Burns
Vice President, Commercial Healthcare Law
and Chief Compliance Officer
Agios Pharmaceuticals

Katherine Chaurette
Senior Director, Assistant General Counsel
Regeneron

Jennifer Chillas
Senior Corporate Counsel
Bristol-Myers Squibb

Jonathan Connell
Senior Counsel
Bristol-Myers Squibb

Bernard Cooney
Assistant United States Attorney, District of New Jersey
U.S. Department of Justice

Chris Dowd
Executive Vice President,
Market and Product Development
ConnectiveRx

Robert Duffield
Counsel
Novo Nordisk Inc.

Allison Frisbee
Corporate Counsel, U.S. Market Access
Jazz Pharmaceuticals, Inc.

William Harris
Assistant General Counsel
Sanofi

Stefanie L. Hill, Esq.
Senior Compliance Manager
Otsuka America Pharmaceutical, Inc.

Rahul Khara, Pharm.D., Esq.
Senior Director, Compliance and Commercial Counsel
Acceleron Pharma Inc.

Richard Konzelmann
Senior Manager, U.S. Ethics and Business Integrity
Sanofi US

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

Jennifer McGee
Vice President and Chief Compliance Officer
Otsuka America Pharmaceutical, Inc.

John Moose
Principal
Polaris, a QuintilesIMS Company

Charles D. Rome, Esq.
Associate Director, Compliance
Novo Nordisk Inc.

Eric Rubenstein
Special Agent,
U.S. Department of Health and Human Services
Office of the Inspector General

William Sarraille
Partner
Sidley Austin LLP

Keren Tenenbaum
Assistant General Counsel
Pfizer Inc.

Jim Vollins
General Counsel, Chief Compliance Officer
BioDelivery Services International, Inc.

Debbie Walters-Francique
Vice President, Assistant General Counsel,
Pfizer Inc.

Trevor Wear
Partner
Sidley Austin LLP

Donna White
Vice President, Contracts and Compliance
Chiesi USA, Inc.

James Accumanno
Director, Risk, Monitoring & Auditing
Novo Nordisk Inc.

Michelle D. Axelrod
Principal, Porzio, Bromberg & Newman, PC;
Vice President, Porzio Life Sciences, LLC

Kosha R. Brightwell
Consultant

James Burns
Vice President, Commercial Healthcare Law
and Chief Compliance Officer
Agios Pharmaceuticals

Katherine Chaurette
Senior Director, Assistant General Counsel
Regeneron

Jennifer Chillas
Senior Corporate Counsel
Bristol-Myers Squibb

Jonathan Connell
Senior Counsel
Bristol-Myers Squibb

Bernard Cooney
Assistant United States Attorney, District of New Jersey
U.S. Department of Justice

Chris Dowd
Executive Vice President,
Market and Product Development
ConnectiveRx

Robert Duffield
Counsel
Novo Nordisk Inc.

Allison Frisbee
Corporate Counsel, U.S. Market Access
Jazz Pharmaceuticals, Inc.

William Harris
Assistant General Counsel
Sanofi

Stefanie L. Hill, Esq.
Senior Compliance Manager
Otsuka America Pharmaceutical, Inc.

Rahul Khara, Pharm.D., Esq.
Senior Director, Compliance and Commercial Counsel
Acceleron Pharma Inc.

Richard Konzelmann
Senior Manager, U.S. Ethics and Business Integrity
Sanofi US

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

Jennifer McGee
Vice President and Chief Compliance Officer
Otsuka America Pharmaceutical, Inc.

John Moose
Principal
Polaris, a QuintilesIMS Company

Charles D. Rome, Esq.
Associate Director, Compliance
Novo Nordisk Inc.

Eric Rubenstein
Special Agent,
U.S. Department of Health and Human Services
Office of the Inspector General

William Sarraille
Partner
Sidley Austin LLP

Keren Tenenbaum
Assistant General Counsel
Pfizer Inc.

Jim Vollins
General Counsel, Chief Compliance Officer
BioDelivery Services International, Inc.

Debbie Walters-Francique
Vice President, Assistant General Counsel,
Pfizer Inc.

Trevor Wear
Partner
Sidley Austin LLP

Donna White
Vice President, Contracts and Compliance
Chiesi USA, Inc.